These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20037446)
1. [A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer]. Watanabe F; Honda G; Kurata M; Tsuruta K; Tokashiki T; Funada N Gan To Kagaku Ryoho; 2009 Nov; 36(12):2430-2. PubMed ID: 20037446 [TBL] [Abstract][Full Text] [Related]
2. Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer. Amano R; Kimura K; Nakata B; Yamazoe S; Motomura H; Yamamoto A; Tanaka S; Hirakawa K Surgery; 2015 Jul; 158(1):191-200. PubMed ID: 25900035 [TBL] [Abstract][Full Text] [Related]
3. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer. Ke QH; Zhou SQ; Yang JY; Du W; Liang G; Lei Y; Luo F World J Gastroenterol; 2014 Oct; 20(38):13987-92. PubMed ID: 25320537 [TBL] [Abstract][Full Text] [Related]
4. [A case of curatively resected locally advanced pancreatic cancer with combined resection of the portal vein and common hepatic artery after neoadjuvant chemotherapy]. Kawaguchi K; Motoi F; Yokoyama S; Takemura S; Doi T; Nozawa Y; Fujishima F; Unno M; Kuroda F Gan To Kagaku Ryoho; 2013 Nov; 40(12):1875-7. PubMed ID: 24393951 [TBL] [Abstract][Full Text] [Related]
5. A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement. Nagakawa Y; Hosokawa Y; Nakayama H; Sahara Y; Takishita C; Nakajima T; Hijikata Y; Kasuya K; Katsumata K; Tokuuye K; Tsuchida A Cancer Chemother Pharmacol; 2017 May; 79(5):951-957. PubMed ID: 28378027 [TBL] [Abstract][Full Text] [Related]
6. [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy]. Hasegawa K; Katsuta E; Iwata N; Aoyagi H; Yoshida T; Takahata T; Kaneko J; Maejima S Gan To Kagaku Ryoho; 2011 Nov; 38(12):2152-4. PubMed ID: 22202313 [TBL] [Abstract][Full Text] [Related]
7. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442 [TBL] [Abstract][Full Text] [Related]
8. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives]. Murakami Y; Uemura K; Sudo T Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141 [No Abstract] [Full Text] [Related]
9. [A case of locally advanced pancreatic cancer with hepatic artery invasion treated with neoadjuvant chemoradiotherapy]. Murata A; Kimura K; Amano R; Hirata K; Nagahara H; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Otani H; Maeda K; Ohira M; Hirakawa K Gan To Kagaku Ryoho; 2013 Nov; 40(12):1865-7. PubMed ID: 24393948 [TBL] [Abstract][Full Text] [Related]
10. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Nakachi K; Furuse J; Kinoshita T; Kawashima M; Ishii H; Ikeda M; Mitsunaga S; Shimizu S Cancer Chemother Pharmacol; 2010 Aug; 66(3):527-34. PubMed ID: 19967537 [TBL] [Abstract][Full Text] [Related]
11. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1]. Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123 [TBL] [Abstract][Full Text] [Related]
12. [A Case of Radical Resection for Locally Advanced Pancreatic Cancer with Positive Peritoneal Cytology Treated with Chemoradiotherapy]. Sato R; Takizawa K; Yuza K; Soma D; Hirose Y; Morimoto Y; Miura K; Nagahashi M; Takano K; Sakata J; Kameyama H; Kobayashi T; Minagawa M; Kosugi S; Wakai T Gan To Kagaku Ryoho; 2015 Nov; 42(12):2385-7. PubMed ID: 26805372 [TBL] [Abstract][Full Text] [Related]
13. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1). Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842 [TBL] [Abstract][Full Text] [Related]
14. [Radical resection of a locally advanced pancreatic tail adenosquamous carcinoma treated with S-1 and gemcitabine as neoadjuvant chemotherapy - a case report]. Sumiyoshi H; Matsushita A; Nakamura Y; Yamahatsu K; Katsuno A; Uchida E Gan To Kagaku Ryoho; 2014 May; 41(5):669-72. PubMed ID: 24917020 [TBL] [Abstract][Full Text] [Related]
15. A phase 1 study of gemcitabine/nab-paclitaxel/S-1 (GAS) combination neoadjuvant chemotherapy for patients with locally advanced pancreatic adenocarcinoma. Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakagawa N; Takahashi S; Ohge H; Sueda T Cancer Chemother Pharmacol; 2017 Apr; 79(4):775-781. PubMed ID: 28293715 [TBL] [Abstract][Full Text] [Related]
16. [A case of locally advanced pancreatic cancer successfully resected after gemcitabine+S-1 therapy]. Moriyama M; Sawada S; Matsui K; Yoshioka I; Shibuya K; Osawa S; Yoshida T; Nagata T; Tsukada K Gan To Kagaku Ryoho; 2014 Nov; 41(12):2187-9. PubMed ID: 25731465 [TBL] [Abstract][Full Text] [Related]
17. [Pancreatic cancer showing complete pathological response to preoperative chemoradiotherapy-a case report]. Tanizaki K; Hama N; Tomimaru Y; Eguchi H; Akita H; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y; Nagano H Gan To Kagaku Ryoho; 2013 Nov; 40(12):1872-4. PubMed ID: 24393950 [TBL] [Abstract][Full Text] [Related]
18. [Adjuvant Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer following Gemcitabine and S-1 Chemotherapy--A Case Report]. Tono T; Kawasaki Y; Hashimoto M; Ikeda Y; Senba H; Okubo Y; Katayama T; Ishii T; Shinozaki K; Hayashi H; Yasuda S; Ohtsuru M Gan To Kagaku Ryoho; 2015 Nov; 42(12):2373-5. PubMed ID: 26805368 [TBL] [Abstract][Full Text] [Related]
19. Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01). Hayashi T; Nakamura T; Kimura Y; Yoshida M; Someya M; Kawakami H; Sakuhara Y; Katoh N; Takahashi K; Ambo Y; Miura K; Motoya M; Tanaka E; Murakawa K; Yamabuki T; Yamazaki H; Katanuma A; Hirano S; Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):606-617. PubMed ID: 31306735 [TBL] [Abstract][Full Text] [Related]
20. [A case of successful R0 resection after neoadjuvant therapy for locally advanced unresectable pancreatic cancer]. Aoki S; Mizuma M; Motoi F; Fukase K; Sakata N; Nakagawa K; Okada T; Hayashi H; Morikawa T; Yoshida H; Naitoh T; Katayose Y; Egawa S; Unno M Gan To Kagaku Ryoho; 2013 Nov; 40(12):1868-71. PubMed ID: 24393949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]